GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Right now, for the rechargeable SCS segment ... for 2025 dropped from $435-445m to $400m-$405m. Boston Scientific’s Wavewriter spinal cord stimulator systems, for example, gained access to ...

Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency ...

In Neuromodulation, growth is expected to have been driven by strong demand in international markets for the Eterna rechargeable spinal cord ... another competitor, Boston Scientific’s BSX ...

Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute.

It didn’t restore normal movement but with just a few hours of spinal stimulation a week ... payout to Michael Flaherty after dismissal from Boston Water and Sewer Michelle Wu says she was ...

The question was meant as a moment of levity, but it cut to the trepidation of scientific communities across the nation in the early days of President Trump’s new administration. “Is anyone ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...